• Dabigatran Metabolite DABG Has Weaker Anticoagulant Action T

  2026-06-18

  This study clarifies that dabigatran acylglucuronide (DABG), the principal metabolite of dabigatran (Pradaxa), exhibits significantly weaker anticoagulant effects than the parent compound. The findings refine our understanding of dabigatran’s pharmacodynamics and inform both research assay design and clinical interpretation of coagulation function tests.

• EdU Imaging Kits (Cy3): Sensitive S-Phase Detection in Proli

  2026-06-18

  EdU Imaging Kits (Cy3) deliver rapid, antibody-free detection of DNA synthesis, enabling high-sensitivity cell proliferation analysis while preserving cellular morphology. Optimized for both fluorescence microscopy and flow cytometry, these kits outperform conventional BrdU approaches and offer a transformative workflow for cancer and genotoxicity research.

• Modeling Human Pacemaker Maturation with SAN-Plexus Assemblo

  2026-06-17

  This study introduces a human stem cell-derived tri-assembloid platform that integrates sinoatrial node, cardiac ganglionated plexus, and atrial organoids to model neuro-cardiac interactions central to pacemaker maturation. The approach enables mechanistic dissection of neuron-to-pacemaker signaling and provides a foundation for translational cardiovascular research.

• NEDD4 Suppresses LUAD Glycolysis via ZBTB7B/ADPGK Axis Inhib

  2026-06-17

  This study identifies a novel regulatory pathway in lung adenocarcinoma (LUAD) in which NEDD4 ubiquitin ligase targets the transcription factor ZBTB7B, leading to decreased ADPGK expression and impaired glycolysis. The findings illuminate new molecular links between transcriptional and post-translational regulation of cancer metabolism, highlighting actionable targets for future metabolic interventions.

• Bifendate (DDB): Mechanistic Leverage for Translational Hepa

  2026-06-16

  This thought-leadership article synthesizes mechanistic insights and strategic guidance for translational researchers utilizing Bifendate (DDB) as a next-generation hepatoprotection agent. Anchored in recent experimental and clinical findings, it explores autophagy inhibition, lipid metabolism regulation, and genotype-dependent drug interactions, providing actionable protocol parameters and visionary perspectives for the evolving landscape of liver disease research.

• Eicosapentaenoic Acid: Workflow Enhancements for Cardiovascu

  2026-06-16

  Eicosapentaenoic Acid (EPA) from APExBIO empowers cardiovascular and inflammation research through reproducible protocols and robust membrane modulation. Discover advanced workflow strategies, troubleshooting insights, and actionable assay improvements that set EPA omega-3 fatty acid apart for translational applications.

• Cy5 amine (non-sulfonated): Technical Guide for Sensitive La

  2026-06-15

  Cy5 amine (non-sulfonated) solves the challenge of labeling biomolecules in workflows requiring bright, photostable dyes that are insoluble in water. It is suitable for protein, peptide, and polymer conjugation in fluorescence microscopy and flow cytometry, but should not be used for direct aqueous labeling or for diagnostic purposes.

• IGF2BP2 Inhibition Disrupts Cell Cycle and Glycolysis in Ova

  2026-06-15

  This study identifies IGF2BP2 as a key m6A RNA modification reader upregulated in malignant ovarian epithelial cells. Through combined single-cell analysis and functional assays, the authors show that inhibiting IGF2BP2 impairs cell cycle progression and glycolytic metabolism, suggesting a potential therapeutic target for ovarian cancer.

• Everolimus (RAD001): Deconstructing mTOR Inhibition Dynamics

  2026-06-14

  Explore the intricate dynamics of Everolimus (RAD001) as an mTOR pathway inhibitor, with an in-depth focus on its mechanistic nuance and the impact of assay selection in cancer research. This article uniquely bridges quantitative drug response metrics with practical guidance for experimental design.

• PERK–JAK1–STAT3 Axis Drives Pyroptosis in Disc Degeneration

  2026-06-13

  This study uncovers how endoplasmic reticulum stress accelerates inflammatory cell death in nucleus pulposus cells via PERK-dependent JAK1–STAT3 signaling, directly linking ER stress to intervertebral disc degeneration. The findings clarify the molecular pathway connecting the unfolded protein response to pyroptosis, highlighting new potential therapeutic targets for mitigating disc inflammation and degeneration.

• Protease Inhibitor Cocktail: Precision in Lipid Droplet Assa

  2026-06-12

  The Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO delivers unmatched protein stability for lipid droplet metabolism studies, safeguarding labile complexes during extraction. Its broad-spectrum, ready-to-use formulation empowers high-fidelity workflows for advanced DFCP1-ATGL axis research and beyond.

• Potassium Iodide in Immunotherapy: Protocols & Workflow Adva

  2026-06-12

  Potassium Iodide (KI) is pivotal for bridging classic thyroid protection with advanced immunotherapy and nanotechnology research. Learn how APExBIO’s high-purity KI enables reproducible results, robust protocol design, and effective troubleshooting in complex experimental systems.

• Fingolimod (FTY720): Beyond Immunomodulation in Neuro-Oncolo

  2026-06-11

  Explore the multifaceted roles of Fingolimod (FTY720) as an immunomodulatory agent for MS and a neuroprotective modulator. This in-depth review uncovers its mechanistic innovations and translational opportunities in immune cell engineering.

• PBS Liposomes: Precision Controls for Macrophage Depletion A

  2026-06-11

  PBS Liposomes provide the gold-standard inert control for macrophage depletion workflows, ensuring assay reproducibility and robust data interpretation. Learn how to implement, optimize, and troubleshoot these phosphate-buffered saline liposomes to distinguish genuine biological effects from delivery artifacts in complex in vivo studies.

• Perphenazine: Mechanistic Insights and Experimental Guidance

  2026-06-10

  Explore the multifaceted mechanisms of Perphenazine, a potent dopamine D2 receptor antagonist, with a focus on mitochondria-mediated cell death and host-directed antibacterial activity. This article offers protocol guidance, unique mechanistic depth, and critical analysis for advanced neuropharmacology and immunology research.

16293 records 1/1087 page Next 12345 下5页 Last page